Company / Free Cash Flow per Share
Axsome Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.93
FY2025
5-year range
-$3.35 / -$1.93
FY2021-FY2025
Trend
+29.0%
vs FY2024
Sector context
#131 of 192
Health Care
What the data says
At $-1.93, Axsome Therapeutics, Inc.'s free cash flow per share ranks #131 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-3.35 in FY2023 to $-1.12 in FY2016.
Based on SEC 10-K filings.
-1.93 in FY2025.
Improved from $-3.35 to $-1.93 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 192 in Health CareTop 68% of 192This company -$1.93 Sector average -$19.84
▼
+90.3% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 29.0% year-over-year.
- Ranks #131 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.93 | +29.0% |
| FY2024 | -$2.72 | +18.8% |
| FY2023 | -$3.35 | -8.0% |
| FY2022 | -$3.10 | -7.4% |
| FY2021 | -$2.89 | -36.7% |
| FY2020 | -$2.11 | -54.7% |
| FY2019 | -$1.36 | -21.8% |
| FY2018 | -$1.12 | +3.8% |
| FY2017 | -$1.16 | -4.2% |
| FY2016 | -$1.12 | -78.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026